InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Kung Winston, Chief Financial Officer. Director active across 1 companies, notably PMV Pharmaceuticals, Inc.. In total, 13 filings have been logged. The latest transaction was filed on 20 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
€11,8714,000 shares@ €2.96780.017% mcap8.7% of flow
Common Stock
SEC:0001209191-22-025171:0·
02,725 shares0
Common Stock
SEC:0001209191-22-007754·
02,725 shares0
Common Stock
SEC:0001209191-22-007754:0·
€13,7885,000 shares@ €2.75770.020% mcap22.2% of flow
Common Stock
SEC:0001209191-21-052784·
€13,7885,000 shares@ €2.75770.020% mcap10.1% of flow
Common Stock
SEC:0001209191-21-052784:0·
€12,2084,500 shares@ €2.71280.018% mcap19.6% of flow
Common Stock
SEC:0001209191-21-049724·
€12,2084,500 shares@ €2.71280.018% mcap9.0% of flow
Common Stock
SEC:0001209191-21-049724:0·
€12,2304,500 shares@ €2.71780.018% mcap19.7% of flow
Common Stock
SEC:0001209191-21-046054·
€12,2304,500 shares@ €2.71780.018% mcap9.0% of flow
Common Stock
SEC:0001209191-21-046054:0·
€11,9434,500 shares@ €2.65390.017% mcap19.2% of flow
Common Stock
SEC:0001209191-21-038798·
€11,9434,500 shares@ €2.65390.017% mcap8.8% of flow
Common Stock
SEC:0001209191-21-038798:0·
€12,0144,500 shares@ €2.66970.017% mcap19.3% of flow
Common Stock
SEC:0001209191-21-030096·
€12,0144,500 shares@ €2.66970.017% mcap8.8% of flow
Common Stock
SEC:0001209191-21-030096:0·
13 of 13 declarations
About Kung Winston
Winston Kung is CFO and COO at PMV Pharmaceuticals, Inc. He oversees the financial operations and growth strategy of the company. His expertise in finance and operational management is crucial for the organization's development.
